An existing antibiotic called cefuroxime has been found to block a specific enzyme involved in thyroid hormone activation — a use not previously known — which could lead to new treatments for thyroid conditions.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review would determine whether any other antibiotics or drugs have shown similar D2 inhibition and whether this effect is reproducible across models.
A systematic review and meta-analysis of all published studies reporting deiodinase inhibition by antibiotics or repurposed drugs, with standardized assays, dose-response data, and statistical pooling of effect sizes for D2 inhibition.
An RCT in humans with hyperthyroidism would determine whether cefuroxime improves clinical outcomes compared to standard therapy.
A double-blind, placebo-controlled trial of 150 adults with Graves' disease, randomized to 500 mg oral cefuroxime twice daily or placebo for 12 weeks, with primary endpoints of free T3 reduction, symptom score improvement, and TSH normalization.
Could assess whether patients prescribed cefuroxime for infections show altered thyroid hormone metabolism compared to those on other antibiotics.
A prospective cohort of 5,000 adults prescribed cefuroxime for respiratory infections, matched to 5,000 on other antibiotics, measuring serum TSH, free T4, and free T3 before and 2 weeks after treatment.
Could test whether patients with unexplained low T3 syndrome are more likely to have received cefuroxime than controls.
A case-control study comparing 100 patients with low tissue T3 syndrome to 200 matched controls, assessing prior cefuroxime exposure within 30 days via pharmacy records.
Could identify whether patients recently treated with cefuroxime show different thyroid hormone profiles than those treated with other antibiotics.
A cross-sectional analysis of 1,000 patients with recent antibiotic use, comparing thyroid hormone levels in those treated with cefuroxime versus other cephalosporins or non-antibiotic controls.